DCX and CRABP2 are candidate genes for differential diagnosis between pre‐chemotherapy embryonic and alveolar rhabdomyosarcoma in pediatric patients

DCX and CRABP2 are candidate genes for differential diagnosis between pre‐chemotherapy embryonic and alveolar rhabdomyosarcoma in pediatric patients

ABSTRACT Importance Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. More than 90% of cases are classified as embryonic RMS (ERMS) or alveolar RMS (ARMS). ERMS has a worse prognosis than ARMS. Early differential diagnosis is of paramount importance for optimization of treat...

Full description

Bibliographic Details
Main Authors: Nian Sun, Yeran Yang, Shengcai Wang, Jie Zhang, Jingang Gui, Jun Tai, Lejian He, Jiatong Xu, Yanzhen Li, Xuexi Zhang, Qiaoyin Liu, Zhiyong Liu, Yongli Guo, Xin Ni
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Pediatric Investigation
Subjects:
Alveolar rhabdomyosarcoma
Embryonic rhabdomyosarcoma
DCX
CRABP2
Immunohistochemistry
Online Access:https://doi.org/10.1002/ped4.12278

Internet

https://doi.org/10.1002/ped4.12278

Similar Items